HCA Healthcare (NYSE:HCA) Price Target Raised to $507.00

HCA Healthcare (NYSE:HCA) had its price target hoisted by Leerink Partners from $470.00 to $507.00 in a research note issued to investors on Thursday,MarketScreener reports. The brokerage currently has an outperform rating on the stock.

HCA has been the subject of several other research reports. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. The Goldman Sachs Group upped their price objective on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, October 27th. Barclays boosted their price target on HCA Healthcare from $445.00 to $494.00 and gave the company an “overweight” rating in a report on Monday, October 27th. Wall Street Zen upgraded HCA Healthcare from a “buy” rating to a “strong-buy” rating in a research note on Saturday, October 25th. Finally, Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price target for the company. in a report on Monday, December 15th. Fifteen analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $487.00.

HCA Healthcare Trading Down 3.0%

NYSE:HCA opened at $469.08 on Thursday. The firm has a 50-day moving average price of $480.49 and a two-hundred day moving average price of $430.73. The company has a market capitalization of $107.04 billion, a P/E ratio of 18.13, a price-to-earnings-growth ratio of 1.29 and a beta of 1.36. HCA Healthcare has a twelve month low of $295.00 and a twelve month high of $520.00.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.64 by $1.32. The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company’s quarterly revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $4.90 EPS. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, equities research analysts predict that HCA Healthcare will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were given a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, December 15th. HCA Healthcare’s dividend payout ratio is 11.13%.

Insider Transactions at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On HCA Healthcare

Large investors have recently modified their holdings of the stock. Palisade Asset Management LLC acquired a new stake in HCA Healthcare in the third quarter valued at approximately $26,000. Ameriflex Group Inc. purchased a new stake in HCA Healthcare during the 2nd quarter worth $27,000. Chung Wu Investment Group LLC acquired a new stake in shares of HCA Healthcare during the second quarter valued at about $27,000. Clearstead Trust LLC lifted its stake in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after acquiring an additional 53 shares in the last quarter. Finally, Holos Integrated Wealth LLC purchased a new stake in HCA Healthcare during the 4th quarter worth approximately $29,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Leerink Partners raised its price target on HCA to $507 and kept an “outperform” rating, signaling analyst confidence in HCA’s earnings trajectory and providing a near-term valuation upside catalyst. Leerink Partners lifts price target on HCA Healthcare to $507
• Positive Sentiment: HCA plans to operate 81 freestanding emergency departments in Florida by the end of Q1, reflecting measurable expansion of outpatient / ED capacity that can drive admissions and higher-margin volumes. HCA to have 81 freestanding EDs in Florida by end of Q1
• Positive Sentiment: Regional partnership expansion in Tennessee positions HCA for market share and referral network growth in a fast-growing region. These deals support medium-term revenue expansion without full hospital acquisitions. Tennessee systems to deepen partnership as HCA eyes growth in region
• Neutral Sentiment: HCA promoted Erica Rossitto to chief nurse executive (effective Feb. 1), strengthening nursing leadership for HCA’s 100,000+ nurses — governance/operational news that supports execution but is not an immediate earnings driver. HCA Healthcare Names Erica Rossitto as Chief Nurse Executive
• Neutral Sentiment: Local executive moves (interim chief nurse at an HCA Missouri hospital and other chief nursing appointments) are operational-level items with limited near-term market impact. HCA Missouri hospital names interim chief nurse
• Neutral Sentiment: Third-party health-tech and regional care updates (Medical City Plano CFO change, Memorial Health CT adoption) mentioned in the newsfeed are industry context but not direct HCA drivers. Healthcare Briefs: Medical City Plano’s New CFO and Cariloop’s Partnership With Raymond James
• Negative Sentiment: L1 Capital trimmed its HCA position, citing share-price appreciation; portfolio selling from a notable fund can create near-term supply pressure and contribute to today’s down move. L1 Capital Trimmed HCA Healthcare Due to Share Price Appreciation

About HCA Healthcare

HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.